NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

BioMarin Pharmaceutical Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERBMRN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / BMRN COVERAGE

What’s moving BioMarin Pharmaceutical Inc. now

Current reporting with the operating signal separated from the noise.

01
BioMarin Pharmaceutical Inc. (BMRN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

BioMarin Pharmaceutical Inc. (BMRN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
BioMarin Pharmaceutical Inc.: BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

BioMarin Pharmaceutical Inc.: BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors

The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
BioMarin Pharmaceutical Inc. Announces Appointment of Robert Plenge to its Board of Directors, Effective September 10, 2026

BioMarin Pharmaceutical Inc. Announces Appointment of Robert Plenge to its Board of Directors, Effective September 10, 2026

The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
BioMarin Pharmaceutical Inc. (BMRN) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

BioMarin Pharmaceutical Inc. (BMRN) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory

BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory

The story matters when it changes BioMarin Pharmaceutical Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest BMRN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-06 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-05 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-09-15 · Period 2026-09-15SEC ↗8-KMaterial company eventFiled 2026-09-14 · Period 2026-09-10SEC ↗8-KMaterial company eventFiled 2026-09-01 · Period 2026-08-31SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-21 · Period 2026-06-02SEC ↗4Official SEC filingFiled 2026-09-14 · Period 2026-09-10SEC ↗
EARNINGS / QUARTERLY TRACKER

BioMarin Pharmaceutical Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.